Particle Dynamics announced the completion of a new, state-of-the-art Product and Process Innovation Center located within its US-based, St Louis facilities. Additionally, Particle Dynamics has received three FDA inspections in the past nine months with zero Form 483 observations.
The new, fully integrated innovation center includes development laboratories and pilot-scale processing rooms housing technologies in Spray Drying, Microencapsulation, Continuous Granulation, and Solid Dosage Form Development. Designed for a fully integrated and seamless transition of new products to commercial scale, the new innovation center will streamline process development and enable more rapid commercialization of products into either of the Company's FDA inspected, GMP facilities in St Louis MO and Seymour IN. In addition to the facility and equipment investments, Particle Dynamics has developed a project management infrastructure, and hired leaders in Technical Operations, Innovation, and Sales to fuel the company's next level of growth; supporting customer success aligned with current market trends.
"This investment is fully aligned with our Vision to provide a fully integrated portfolio of products and services to the global Healthcare industry," said Nicolas Fortin, CEO at Particle Dynamics. "Having advanced technologies such as spray drying, microencapsulation, granulation, and advanced dosage form development under one roof will enable us to more rapidly respond with the right technical solutions to meet the needs of our customers."
"The completion of our Product and Process Innovation Center marks a major milestone in providing innovative solutions for our customers," said Chad Dykes, Vice President of Technical Operations. "This new center is the latest in our journey to create a more integrated and agile development process. By consolidating development and manufacturing operations under the same leadership, we will move faster through the development, scale-up and commercialization of solutions for our customers."